Risk/Reward to the extreme, but at this point with the FDA approval for HIV related diarrhea treatment already in place, the cancer CTD approval seems like the next logical step for the FDA. Just need the positive data to back it up. So really JAGX’s near term future depends upon these results to be proven positive with enough evidence to justify FDA approval. But it doesn’t seem like such a long shot to me.
Risk/Reward to the extreme, but at this point with the FDA approval for HIV related diarrhea treatment already in place, the cancer CTD approval seems like the next logical step for the FDA. Just need the positive data to back it up. So really JAGX’s near term future depends upon these results to be proven positive with enough evidence to justify FDA approval. But it doesn’t seem like such a long shot to me.
If volume comes in slowly a short squeeze is probably not going to happen, shorts will cover easily and avoid a squeeze. But I think in the recent trading environment a short squeeze is very likely if very large amounts of volume comes in quickly. Traders love easy fast money, and could drive this up extremely high very quickly. Some of the conditions are already in place. VERY interesting how this will play out. We shall see...
News 
Market Data 
Discover 
